Moreover, DPP-4 inhibition by the gliptins, linagliptin, sitagliptin, and liraglutide, as well DPP-4 KO, improved survival, vascular inflammation, and vascular dysfunction in an animal model of LPS-induced endotoxemia [159]. Here, DPP4 is linked to serum lipopolysaccharide activity.